Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG
Clinical trial NCT07134725 · COMPLETED
Trial details
- NCT number
- NCT07134725
- Sponsor
- Federal University of Minas Gerais
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-23
- Primary completion
- 2023-05-22
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.